Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-19

FDA Approved: LEVETIRACETAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for a generic Levetiracetam product. This notice indicates a supplemental approval to the ANDA,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levetiracetam (generic) (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)